KENNETT SQUARE, Pa., May 07, 2018 -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its first quarter 2018 results before the market opens on Thursday, May 10, 2018. A conference call and webcast will be held on Thursday, May 10, 2018 at 8:30 a.m. Eastern Time to discuss the results. To participate in the call, interested parties may dial (855) 849-2198 or listen to a live webcast and replay of the call on the Company’s website at http://www.genesishcc.com/investor-relations.
About Genesis HealthCare
Genesis HealthCare (NYSE:GEN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's largest post-acute care providers with more than 450 skilled nursing facilities and assisted/senior living communities in 30 states nationwide. Genesis subsidiaries also supply rehabilitation and respiratory therapy to approximately 1,600 healthcare providers in 46 states, the District of Columbia and China. References made in this release to "Genesis," "the Company," "we," "us" and "our" refer to Genesis HealthCare and each of its wholly-owned companies. Visit our website at www.genesishcc.com.
CONTACT:
Investor Relations
Lori Mayer, Genesis HealthCare
610-925-2000


Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Japan Earthquake Disrupts Auto and Chip Supply Chains
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
World game at war: why some European nations have threatened a World Cup boycott
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 



